198 related articles for article (PubMed ID: 24395980)
21. Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.
Hirschl MM; Wollmann CG; Erhart F; Brunner W; Pfeffel F; Gattermeier M; Steger F; Mayr H
Crit Care Med; 2013 Jun; 41(6):1396-404. PubMed ID: 23528803
[TBL] [Abstract][Full Text] [Related]
22. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.
Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW
Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708
[TBL] [Abstract][Full Text] [Related]
23. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
[TBL] [Abstract][Full Text] [Related]
25. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
Czarnecki A; Welsh RC; Yan RT; DeYoung JP; Gallo R; Rose B; Grondin FR; Kornder JM; Wong GC; Fox KA; Gore JM; Goodman SG; Yan AT; ;
Can J Cardiol; 2012; 28(1):40-7. PubMed ID: 22129488
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
27. Mid-term mortality of very elderly patients with acute myocardial infarction with or without coronary intervention.
Kashima K; Ikeda D; Tanaka H; Yamashita E; Nagayoshi S; Yoshishige Y; Tanoue K; Nagano S; Nuruki N; Yoshinaga M; Sonoda M
J Cardiol; 2010 May; 55(3):397-403. PubMed ID: 20350512
[TBL] [Abstract][Full Text] [Related]
28. Is long-term beta-blocker therapy for myocardial infarction survivors still relevant in the era of primary percutaneous coronary intervention?
Shacham Y; Leshem-Rubinow E; Roth A
Isr Med Assoc J; 2013 Dec; 15(12):770-4. PubMed ID: 24449984
[TBL] [Abstract][Full Text] [Related]
29. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
31. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
Raposeiras-Roubín S; Abu-Assi E; Redondo-Diéguez A; González-Ferreiro R; López-López A; Bouzas-Cruz N; Castiñeira-Busto M; Peña Gil C; García-Acuña JM; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):585-91. PubMed ID: 25511558
[TBL] [Abstract][Full Text] [Related]
33. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
34. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
[TBL] [Abstract][Full Text] [Related]
35. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
[TBL] [Abstract][Full Text] [Related]
36. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
Am J Cardiol; 2009 May; 103(10):1333-8. PubMed ID: 19427424
[TBL] [Abstract][Full Text] [Related]
37. Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention.
Lim HS; Stub D; Ajani AE; Andrianopoulos N; Reid CM; Charter K; Black A; Smith K; New G; Chan W; Lim CC; Farouque O; Shaw J; Brennan A; Duffy SJ; Clark DJ
Int J Cardiol; 2013 Jun; 166(2):425-30. PubMed ID: 22133465
[TBL] [Abstract][Full Text] [Related]
38. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
39. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
40. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
